Certolizumab pegol for hidradenitis suppurativa: Case report and literature review

Dermatol Ther. 2020 Nov;33(6):e14494. doi: 10.1111/dth.14494. Epub 2020 Nov 16.

Authors

Jesper Grønlund Holm¹, Astrid-Helene Ravn Jørgensen¹, Yiqiu Yao¹, Simon Francis Thomsen^{1

2}

Affiliations

¹ Department of Dermato-Venereology and Wound Healing Center, Bispebjerg Hospital, Copenhagen, Denmark.
² Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.

PMID: 33135826
DOI: 10.1111/dth.14494

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't
Review

MeSH terms

Antibodies, Monoclonal, Humanized
Certolizumab Pegol
Hidradenitis Suppurativa* / diagnosis
Hidradenitis Suppurativa* / drug therapy
Humans

Substances

Antibodies, Monoclonal, Humanized
Certolizumab Pegol